Zhen Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhen Liu has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Hao Li
Department of Orthopaedics, Shandong University Qilu Hospital, Jinan, 250012, China
4 shared publications- Zhenzhong Li
Department of Anatomy, Shandong University School of Medicine, Jinan, China
4 shared publications - Huaxiang Liu
Department of Rheumatology, Qilu Hospital, Shandong University, Jinan, Shandong Province, China
3 shared publications Zhenzhong Li
Department of Anatomy, Shandong University School of Basic Medical Sciences, Jinan, 250012, China
3 shared publicationsDaoyu Li
Shandong University,School of Electrical Engineering,Jinan,China
1 shared publication- Dong Liu
Department of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN 55812, USA
1 shared publication
Latest Publications
- 29 January 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 141-146
Research on Reactive Power Impact and Optimization of Photovoltaic Power Distribution Network Based on the Concept of Power Flow Direction Change
With the development of the national economy, the distribution network equipment has been continuously upgraded and the operation level has been continuously improved, and the distribution network has gradually developed in the direction of automation, forming an active distribution network with high penetration, high reliability and self-healing rate of distributed power sources. However, the large-scale access of distributed photovoltaics in the active distribution network often leads to problems such as voltage fluctuation, harmonic over-limit and power factor reduction in the distribution network, which has a great impact on the power supply quality of the distribution network. Among them, the reduction of the power factor of the distribution network will lead to an increase in line loss, a decrease in voltage, and a decrease in equipment utilization, which is extremely detrimental to the power quality of the public grid. Based on the actual situation and operation data of distributed photovoltaic in distribution network of XC District, a city in Shandong Province, this paper conducts a practical study on the impact, causes and improvement measures of low-voltage distributed photovoltaic reactive power in active distribution network. Firstly, according to the actual operation of distribution network, the concept of transformer power flow direction change point (stage) is proposed. Then, based on the concept of transformer power flow direction change point (stage), this paper studied the impact of public transformer distributed photovoltaic access on power factor using a large number of operating data, and deeply analyzed the reasons for the reduction of power factor of public transformer connected to distributed photovoltaic through vector method, and then proposed a transformer refined reactive power compensation scheme based on intelligent fusion terminal of distribution transformer. Finally, this paper proved the correctness and scientificity of the research methods and results through an engineering reconstruction example.
- 29 January 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 141-146
Research on Reactive Power Impact and Optimization of Photovoltaic Power Distribution Network Based on the Concept of Power Flow Direction Change
With the development of the national economy, the distribution network equipment has been continuously upgraded and the operation level has been continuously improved, and the distribution network has gradually developed in the direction of automation, forming an active distribution network with high penetration, high reliability and self-healing rate of distributed power sources. However, the large-scale access of distributed photovoltaics in the active distribution network often leads to problems such as voltage fluctuation, harmonic over-limit and power factor reduction in the distribution network, which has a great impact on the power supply quality of the distribution network. Among them, the reduction of the power factor of the distribution network will lead to an increase in line loss, a decrease in voltage, and a decrease in equipment utilization, which is extremely detrimental to the power quality of the public grid. Based on the actual situation and operation data of distributed photovoltaic in distribution network of XC District, a city in Shandong Province, this paper conducts a practical study on the impact, causes and improvement measures of low-voltage distributed photovoltaic reactive power in active distribution network. Firstly, according to the actual operation of distribution network, the concept of transformer power flow direction change point (stage) is proposed. Then, based on the concept of transformer power flow direction change point (stage), this paper studied the impact of public transformer distributed photovoltaic access on power factor using a large number of operating data, and deeply analyzed the reasons for the reduction of power factor of public transformer connected to distributed photovoltaic through vector method, and then proposed a transformer refined reactive power compensation scheme based on intelligent fusion terminal of distribution transformer. Finally, this paper proved the correctness and scientificity of the research methods and results through an engineering reconstruction example.
- 1 August 2021
- Published by Elsevier in Neuroscience Research
- Vol. 169, 9-16
Pim1 kinase provides protection against high glucose-induced stress and apoptosis in cultured dorsal root ganglion neurons
- 1 August 2021
- Published by Elsevier in Neuroscience Research
- Vol. 169, 9-16
Pim1 kinase provides protection against high glucose-induced stress and apoptosis in cultured dorsal root ganglion neurons
- Open Access
- 1 January 2021
- Published by Chinese Center for Disease Control and Prevention in China CDC Weekly
- Vol. 3 (11) , 232-236
Trends of Underweight Malnutrition Among Chinese Residents Aged 60 Years and Above — China, 1992−2015
What is already known about this topic? The prevalence of underweight malnutrition largely decreased in Chinese adults in recent thirty years while obesity became increasingly concerning. However, underweight malnutrition still affected elderly populations and increased risk of anemia, infection diseases, some non-communicable chronic diseases and disability. What is added by this report? In this study, data from 4 national surveys from 1992 to 2015 were analyzed to study underweight malnutrition. There was an 80.5% reduction for underweight malnutrition nationally, including a 67.5% reduction in rural areas and 67.4% in urban areas, and 76.2% in males and 79.4% in females. What are the implications for public health practice? Underweight malnutrition seriously affects the health and quality of life for older people and will lead to heavy burdens for families and society overall. Therefore, efforts should be maintained to screen, treat, and safeguard elderly populations with underweight malnutrition using nutritional improvement strategies, especially for the oldest elderly individuals in rural areas.
- 1 January 2021
- Published by Chinese Center for Disease Control and Prevention in China CDC Weekly
- Vol. 3 (11) , 232-236
Open AccessTrends of Underweight Malnutrition Among Chinese Residents Aged 60 Years and Above — China, 1992−2015
What is already known about this topic? The prevalence of underweight malnutrition largely decreased in Chinese adults in recent thirty years while obesity became increasingly concerning. However, underweight malnutrition still affected elderly populations and increased risk of anemia, infection diseases, some non-communicable chronic diseases and disability. What is added by this report? In this study, data from 4 national surveys from 1992 to 2015 were analyzed to study underweight malnutrition. There was an 80.5% reduction for underweight malnutrition nationally, including a 67.5% reduction in rural areas and 67.4% in urban areas, and 76.2% in males and 79.4% in females. What are the implications for public health practice? Underweight malnutrition seriously affects the health and quality of life for older people and will lead to heavy burdens for families and society overall. Therefore, efforts should be maintained to screen, treat, and safeguard elderly populations with underweight malnutrition using nutritional improvement strategies, especially for the oldest elderly individuals in rural areas.
- Open Access
- 3 January 2020
- Published by Springer Nature in Research Square
The mechanisms of protease-activated receptor 2 in mediating pain behaviors through nonselective cation channel signaling
Background: Activation of purinergic receptor P2X ligand-gated ion channel 3 (P2X3), transient receptor potential vanilloid type 1 (TRPV1), and transient receptor potential ankyrin 1 (TRPA1) by their specific ligands is a major mechanism contributing to magnified pain responses. The relationship between these nonselective cation channels and proteinase-activated receptor 2 (PAR2) activation mediated pain is still to be clarified.Methods: In this study, both in vitro model of dorsal root ganglion (DRG) neurons with PAR2 agonist SL-NH2 challenge and SL-NH2-induced pain rat model were used to approach these questions. The expression of P2X3, TRPV1, and TRPA1 in DRG neurons was investigated by quantitative real-time RT-PCR, Western blot, and immunofluorescence. The involvement of the PLCβ3/PKCε signaling pathway was also determined. The behavior test for mechanical allodynia and thermal hyperalgesia was performed. Results: SL-NH2 induced upregulation of P2X3, TRPV1, and TRPA1 through phosphorylation of phospholipase Cβ3 (PLCβ3) and protein kinase Cε (PKCε) signaling pathway in DRG neurons in vitro and in vivo. SL-NH2 also elevated the proportion of P2X3-, TRPV1-, and TRPA1-expressing neurons. The upregulation of P2X3, TRPV1, and TRPA1 and phosphorylation of PLCβ3 and PKCε in DRG neurons was paralleled with mechanical allodynia and thermal hyperalgesia behaviors in rats. Conclusions: The data of the present study imply that SL-NH2 as a noxious stimulus activates PAR2 which induces TRPV1, TRPA1, and P2X3 upregulation through PLCβ3/PKCε signaling pathway, thereby decreasing activation thresholds and increasing excitability, resulting in sustained nociceptive activity in DRG neurons, and then causing mechanical allodynia and thermal hyperalgesia behaviors. These data expanded our knowledge about PAR2-mediated pain sensitivity and its relationship with TRPV1, TRPA1, and P2X3 and provided new opportunities on management of pain behaviors.
- 3 January 2020
- Published by Springer Nature in Research Square
Open AccessThe mechanisms of protease-activated receptor 2 in mediating pain behaviors through nonselective cation channel signaling
Background: Activation of purinergic receptor P2X ligand-gated ion channel 3 (P2X3), transient receptor potential vanilloid type 1 (TRPV1), and transient receptor potential ankyrin 1 (TRPA1) by their specific ligands is a major mechanism contributing to magnified pain responses. The relationship between these nonselective cation channels and proteinase-activated receptor 2 (PAR2) activation mediated pain is still to be clarified.Methods: In this study, both in vitro model of dorsal root ganglion (DRG) neurons with PAR2 agonist SL-NH2 challenge and SL-NH2-induced pain rat model were used to approach these questions. The expression of P2X3, TRPV1, and TRPA1 in DRG neurons was investigated by quantitative real-time RT-PCR, Western blot, and immunofluorescence. The involvement of the PLCβ3/PKCε signaling pathway was also determined. The behavior test for mechanical allodynia and thermal hyperalgesia was performed. Results: SL-NH2 induced upregulation of P2X3, TRPV1, and TRPA1 through phosphorylation of phospholipase Cβ3 (PLCβ3) and protein kinase Cε (PKCε) signaling pathway in DRG neurons in vitro and in vivo. SL-NH2 also elevated the proportion of P2X3-, TRPV1-, and TRPA1-expressing neurons. The upregulation of P2X3, TRPV1, and TRPA1 and phosphorylation of PLCβ3 and PKCε in DRG neurons was paralleled with mechanical allodynia and thermal hyperalgesia behaviors in rats. Conclusions: The data of the present study imply that SL-NH2 as a noxious stimulus activates PAR2 which induces TRPV1, TRPA1, and P2X3 upregulation through PLCβ3/PKCε signaling pathway, thereby decreasing activation thresholds and increasing excitability, resulting in sustained nociceptive activity in DRG neurons, and then causing mechanical allodynia and thermal hyperalgesia behaviors. These data expanded our knowledge about PAR2-mediated pain sensitivity and its relationship with TRPV1, TRPA1, and P2X3 and provided new opportunities on management of pain behaviors.
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 8143754
The Actions and Mechanisms of P2X7R and p38 MAPK Activation in Mediating Bortezomib‐Induced Neuropathic Pain
The proteasome inhibitor bortezomib (BTZ) is a potent first‐line anticancer drug for multiple myeloma; nonetheless, it induced peripheral neuropathy. It has been suggested that many cytokines may play a role in mediating neuropathic pain, but the underlying molecular mechanism is not fully understood. Recent studies have shown that neuropathic pain is closely related to the purinergic ligand‐gated ion channel 7 receptor (P2X7R), one of the P2X receptors, which is richly expressed in glial cells. P2X7‐p38 pathway is correlated with microglia‐ and satellite glial cell‐ (SGC‐) mediated neuropathic pain. However, the association of P2X7R and p38MAPK in mediating BTZ‐induced neuropathic pain remains unclear. In this study, the relationship between P2X7R activation and p38 phosphorylation in the dorsal root ganglion (DRG) and spinal dorsal horn (SDH) in the development and maintenance of BTZ‐induced neuropathic pain was elucidated. The results showed that BTZ increased mechanical thresholds in rats, accompanied with upregulation of P2X7R expression and p38MAPK phosphorylation, indicating that P2X7R and p38MAPK are key molecules in the development and maintenance of BTZ‐induced neuropathic pain. Inhibiting p38MAPK phosphorylation with SB203580 resulted in downregulation of P2X7R expression levels. Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and IL‐6 via inhibiting p38MAPK phosphorylation. The P2X7R/p38MAPK signaling pathway in SGCs of DRG and microglia of SDH might be a potential pharmacological target behind this mechanism as an opportunity to relieve BTZ‐induced neuropathic pain.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 8143754
Open AccessThe Actions and Mechanisms of P2X7R and p38 MAPK Activation in Mediating Bortezomib‐Induced Neuropathic Pain
The proteasome inhibitor bortezomib (BTZ) is a potent first‐line anticancer drug for multiple myeloma; nonetheless, it induced peripheral neuropathy. It has been suggested that many cytokines may play a role in mediating neuropathic pain, but the underlying molecular mechanism is not fully understood. Recent studies have shown that neuropathic pain is closely related to the purinergic ligand‐gated ion channel 7 receptor (P2X7R), one of the P2X receptors, which is richly expressed in glial cells. P2X7‐p38 pathway is correlated with microglia‐ and satellite glial cell‐ (SGC‐) mediated neuropathic pain. However, the association of P2X7R and p38MAPK in mediating BTZ‐induced neuropathic pain remains unclear. In this study, the relationship between P2X7R activation and p38 phosphorylation in the dorsal root ganglion (DRG) and spinal dorsal horn (SDH) in the development and maintenance of BTZ‐induced neuropathic pain was elucidated. The results showed that BTZ increased mechanical thresholds in rats, accompanied with upregulation of P2X7R expression and p38MAPK phosphorylation, indicating that P2X7R and p38MAPK are key molecules in the development and maintenance of BTZ‐induced neuropathic pain. Inhibiting p38MAPK phosphorylation with SB203580 resulted in downregulation of P2X7R expression levels. Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and IL‐6 via inhibiting p38MAPK phosphorylation. The P2X7R/p38MAPK signaling pathway in SGCs of DRG and microglia of SDH might be a potential pharmacological target behind this mechanism as an opportunity to relieve BTZ‐induced neuropathic pain.
- 10 July 2016
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 33 (3) , 250-264
The protective effects of insulin-like growth factor-1 on neurochemical phenotypes of dorsal root ganglion neurons with BDE-209-induced neurotoxicity in vitro
Polybrominated diphenyl ethers (PBDEs) exist extensively in the environment as contaminants, in which 2,2′,3,3′,4,4′,5,5′,6,6′-decabrominated diphenyl ether (BDE-209) is the most abundant PBDE found in human samples. BDE-209 has been shown to cause neurotoxicity of primary sensory neurons with few effective therapeutic options available. Here, cultured dorsal root ganglion (DRG) neurons were used to determine the therapeutic effects of insulin-like growth factor-1 (IGF-1) on BDE-209-induced neurotoxicity. The results showed that IGF-1 promoted neurite outgrowth and cell viability of DRG neurons with BDE-209-induced neurotoxicity. IGF-1 inhibited oxidative stress and apoptotic cell death caused by BDE-209 exposure. IGF-1 could reverse the decrease in growth-associated protein-43 (GAP-43) and calcitonin gene-related peptide (CGRP), but not neurofilament-200 (NF-200), expression resulting from BDE-209 exposure. The effects of IGF-1 could be blocked by the extracellular signal-regulated protein kinase (ERK1/2) inhibitor PD98059 and the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002, either alone or in combination. IGF-1 may play an important role in neuroprotective effects on DRG neurons with BDE-209-induced neurotoxicity through inhibiting oxidative stress and apoptosis and regulating GAP-43 and CGRP expression of DRG neurons. Both ERK1/2 and PI3K/Akt signaling pathways were involved in the effects of IGF-1. Thus, IGF-1 might be one of the therapeutic agents on BDE-209-induced neurotoxicity.
- 10 July 2016
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 33 (3) , 250-264
The protective effects of insulin-like growth factor-1 on neurochemical phenotypes of dorsal root ganglion neurons with BDE-209-induced neurotoxicity in vitro
Polybrominated diphenyl ethers (PBDEs) exist extensively in the environment as contaminants, in which 2,2′,3,3′,4,4′,5,5′,6,6′-decabrominated diphenyl ether (BDE-209) is the most abundant PBDE found in human samples. BDE-209 has been shown to cause neurotoxicity of primary sensory neurons with few effective therapeutic options available. Here, cultured dorsal root ganglion (DRG) neurons were used to determine the therapeutic effects of insulin-like growth factor-1 (IGF-1) on BDE-209-induced neurotoxicity. The results showed that IGF-1 promoted neurite outgrowth and cell viability of DRG neurons with BDE-209-induced neurotoxicity. IGF-1 inhibited oxidative stress and apoptotic cell death caused by BDE-209 exposure. IGF-1 could reverse the decrease in growth-associated protein-43 (GAP-43) and calcitonin gene-related peptide (CGRP), but not neurofilament-200 (NF-200), expression resulting from BDE-209 exposure. The effects of IGF-1 could be blocked by the extracellular signal-regulated protein kinase (ERK1/2) inhibitor PD98059 and the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002, either alone or in combination. IGF-1 may play an important role in neuroprotective effects on DRG neurons with BDE-209-induced neurotoxicity through inhibiting oxidative stress and apoptosis and regulating GAP-43 and CGRP expression of DRG neurons. Both ERK1/2 and PI3K/Akt signaling pathways were involved in the effects of IGF-1. Thus, IGF-1 might be one of the therapeutic agents on BDE-209-induced neurotoxicity.
- 14 January 2015
- Published by Springer Nature in Neurochemical Research
- Vol. 40 (4) , 698-712
Erythropoietin Attenuates Advanced Glycation Endproducts-Induced Toxicity of Schwann Cells In Vitro
Advanced glycation endproducts (AGEs)-induced cytotoxicity is regarded as one of the main mechanisms responsible for neurological disorders. Although erythropoietin (EPO) is demonstrated to have neuroprotective effects in neurodegenerative diseases, the effects of EPO on AGEs-induced toxicity of Schwann cells (SCs) remain open for investigation. Primary cultured SCs isolated from 4 day-old Wistar rats were exposed to AGEs with or without EPO treatment for 5 days. AGEs decreased cell viability, increased apoptotic rate, elevated intracellular reactive oxygen species levels, and reduced total glutathione levels of SCs. The AGEs-induced toxic effects on SCs were partially blocked by AGER siRNA or AGER inhibitor FPS-ZM1. SCs exposed to AGEs exhibited higher mRNA and protein levels of receptor for AGEs (AGER), EPO, and EPO receptor (EPOR). Exogenous EPO treatment attenuated AGEs-induced oxidative stress and apoptosis probably by reducing the mRNA and protein expression of AGER. The protective effect of EPO against AGEs-induced toxicity was blocked by EPOR siRNA. The data of the present study gives, for the first time, evidence of the protective effects of EPO on SCs with AGEs-induced oxidative stress and apoptosis. These results imply that EPO might be a novel valuable agent for treating AGEs-induced toxicity.
- 14 January 2015
- Published by Springer Nature in Neurochemical Research
- Vol. 40 (4) , 698-712
Erythropoietin Attenuates Advanced Glycation Endproducts-Induced Toxicity of Schwann Cells In Vitro
Advanced glycation endproducts (AGEs)-induced cytotoxicity is regarded as one of the main mechanisms responsible for neurological disorders. Although erythropoietin (EPO) is demonstrated to have neuroprotective effects in neurodegenerative diseases, the effects of EPO on AGEs-induced toxicity of Schwann cells (SCs) remain open for investigation. Primary cultured SCs isolated from 4 day-old Wistar rats were exposed to AGEs with or without EPO treatment for 5 days. AGEs decreased cell viability, increased apoptotic rate, elevated intracellular reactive oxygen species levels, and reduced total glutathione levels of SCs. The AGEs-induced toxic effects on SCs were partially blocked by AGER siRNA or AGER inhibitor FPS-ZM1. SCs exposed to AGEs exhibited higher mRNA and protein levels of receptor for AGEs (AGER), EPO, and EPO receptor (EPOR). Exogenous EPO treatment attenuated AGEs-induced oxidative stress and apoptosis probably by reducing the mRNA and protein expression of AGER. The protective effect of EPO against AGEs-induced toxicity was blocked by EPOR siRNA. The data of the present study gives, for the first time, evidence of the protective effects of EPO on SCs with AGEs-induced oxidative stress and apoptosis. These results imply that EPO might be a novel valuable agent for treating AGEs-induced toxicity.
- 1 June 2013
- Published by Elsevier in Regulatory Peptides
- Vol. 184, 68-74
Different responses of galanin and calcitonin gene-related peptide to capsaicin stimulation on dorsal root ganglion neurons in vitro
- 1 June 2013
- Published by Elsevier in Regulatory Peptides
- Vol. 184, 68-74
Different responses of galanin and calcitonin gene-related peptide to capsaicin stimulation on dorsal root ganglion neurons in vitro